As part of a May 15 reorganization, US FDA has established a new pharmaceutical inspectorate in its Office of Regulatory Affairs and apportioned the inspectorate's staff among four domestic regional divisions, one foreign division and one program division.
The reorganization, called program alignment, enables the agency's field organization to specialize by type of product. Investigators will no long be inspecting a food facility one week and a drug facility the next
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?